Bernstein SocGen Group revised its price target for Regeneron (NASDAQ:REGN) Pharmaceuticals (NASDAQ: REGN) to $1,000 from the previous $1,070, while retaining an Outperform rating on the stock.
In a report released yesterday, Daniel Perlin from RBC Capital maintained a Buy rating on Visa (V – Research Report), with a price target of ...
- Tariffs on Mexico could hurt appliance distributors such as Whirlpool, BofA Global Research said. About 40% of the U.S.
President Vladimir Putin is allowing Goldman Sachs Group Inc. to sell its business in Russia, making the US firm one of the ...
Alternative lending giant Goldman Sachs Asset Management is looking to raise as much as $3 billion for a new climate credit ...
Global policymakers and Wall Street analysts have been bracing for massive trade barriers from the new Trump administration. But it focused more on the domestic front in the first week in power, ...
Between you-only-live-once retail traders, big corporates buying back their stock and retirement allocation demand, the bears ...
Capital One Financial Corp (NYSE:COF), a $78 billion market cap financial services giant, announced the closure of a public ...
Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE: ARE) today announced that it has priced a public ...
On Wednesday after the bell, Meta (META) reported fourth-quarter results, where it topped forecasts for revenues, profit, and ...
ServiceNow provided solid fourth quarter results, but shares sank 12% during Thursday trading as more meaningful revenue ...
Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") today announced that it is commencing an underwritten public offering, subject to market conditions, of senior notes (the "notes") ...